Investigating health issues in children who were born prematurely
Clinical and Biochemical Features of Metabolic Dysregulation in Formerly Preterm Children
This study is looking at kids aged 5-12 who were born early to see how their health might be affected as they grow up, especially regarding their lungs, weight, and risk of diabetes, so we can find ways to help them live healthier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11075282 on NIH RePORTER |
What this research studies
This research focuses on children aged 5-12 who were born prematurely, examining their long-term health outcomes related to cardiopulmonary and metabolic conditions. The study aims to identify any hidden health problems that may arise from their early birth, such as issues with lung function, obesity, and diabetes. By analyzing biological markers and considering social factors that may affect their health, the research seeks to understand how these children can be better supported as they grow. The findings could lead to early interventions that improve their overall health and quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 5-12 who were born prematurely at less than 34 weeks of gestation.
Not a fit: Patients who were not born prematurely or are older than 12 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health monitoring and interventions for children born prematurely, potentially reducing their risk of long-term health complications.
How similar studies have performed: Previous research has indicated that similar approaches to studying health outcomes in premature infants have yielded valuable insights, suggesting this study builds on established findings.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Austin, Eric Douglas — Vanderbilt University Medical Center
- Study coordinator: Austin, Eric Douglas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.